Last updated on February 2018

AMH Glucose Intolerance and Metabolic Syndrome in PCOS


Brief description of study

Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)

Detailed Study Description

  • To study the association between serum anti-Mullerian hormone (AMH) level and glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS).
    • Glucose intolerance is detected by 2-hours 75 gram oral glucose tolerance test (OGTT).
    • Metabolic syndrome is diagnosed by using the Harmonized criteria; the presence of any 3 of 5 following risk factors constitutes a diagnosis of metabolic syndrome.
      1. Elevated waist circumference (> 80 cm in Asian women)
      2. Elevated triglycerides (> 150 mg/dL)
      3. Reduced HDL-cholesterol (< 50 mg/dL)
      4. Elevated blood pressure )systolic > 130 and/or diastolic > 85 mmHg)
      5. Elevated fasting glucose ( > 100 mg/dL)
    • Percentage of glucose intolerance and metabolic syndrome in PCOS women as well was any differences in parameters between PCOS patients with and without glucose intolerance and metabolic syndrome will be analysed.

Clinical Study Identifier: NCT02676518

Contact Investigators or Research Sites near you

Start Over

Wasamon Tunsuparp, MD

Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand
  Connect »